Newsletter | July 31, 2026

07.31.26 -- Repurposing Legacy Infrastructure For Biopharma Resilience

SPONSOR

Join this Outsourced Pharma Live discussion: Charting a Direct Pathway from Academia To CDMOs on August 4, 2026 to learn how academic innovators, technology transfer offices, and CDMOs can bridge critical gaps in documentation, quality expectations, and development strategy. Hear practical advice on creating stronger technical packages, aligning earlier with CDMO partners, and accelerating the path from promising research to real-world manufacturing success. Register.

INDUSTRY INSIGHTS

Annex 1 FAQs: How Is Behavior Changing As A Result Of EU GMP Annex 1?

EU GMP Annex 1 is driving changes in how teams behave inside cleanrooms. Understand what contamination awareness means in practice and how to build a culture where speaking up is standard.

6 Strategic Pillars For Selecting A Drug Packaging Partner

Early engagement with an expert packaging partner supports safe, cost-effective drug development and logistical success from precommercial stages through full market launch.

Navigating Nitrosamine Impurities In Pharmaceutical Drug Development

Understanding formation mechanisms and potency categorization allows developers to mitigate risks early, ensuring regulatory compliance and patient safety without compromising product performance.

FEATURED EDITORIAL

Repurposing Legacy Infrastructure For Biopharma Resilience

Well, that didn’t work out as planned, writes Chief Editor Louis Garguilo, referring to Kodak's plan in 2018 to revitalize the Eastman Business Park in Rochester, NY. The incoming chairman and now CEO, Jim Continenza, didn’t like that movie, and flipped the script. Instead, Kodak has, so to speak, returned to itself – back to a domestic specialty materials and chemicals supplier, intent on serving biopharma in that capacity.

Turning Operational Efficiency Into Margin Recovery

The pricing dynamics for generic drugs turns formerly attractive products into high-volume, low-margin commodities. Lean and Six Sigma in four key areas can unlock efficiencies.

INDUSTRY INSIGHTS CONTINUED

Prioritize Solvent Recycling And Recovery To Realize Your Green Goals

Building more sustainable practices across the pharmaceutical industry takes a collaborative and transparent effort. One leading CDMO is leveraging its solvent recovery efforts to yield major strides.

Why CDMO Performance Drops Exactly When It Matters Most

Programs often stall moving to GMP due to fragmented workflows and knowledge gaps. Aligning teams and integrating development with execution, via continuous data, sustains momentum and reduces risk.

A Complete Guide For Encapsulation Issues Caused By Sticky Formulations

Discover best practices for overcoming sticky formulation issues in capsule filling. This guide offers step-by-step troubleshooting methods to ensure smooth and efficient encapsulation processes.

SOLUTIONS

Get Drug Formulation Right From The Start

Solid Form Screening

Drug Metabolism And Pharmacokinetics (DMPK)

OUTSOURCED PHARMA CAPABILITIES UPDATE

Find Your New CDMO At Outsourced Pharma Capabilities Update

CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capabilities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs.

Connect With Outsourced Pharma: